Evidence map›Paper›PMID 24133248›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

α2δ-1 gene deletion affects somatosensory neuron function and delays mechanical hypersensitivity in response to peripheral nerve damage.

Ryan Patel, Claudia S Bauer, Manuela Nieto-Rostro, Wojciech Margas, Laurent Ferron, Kanchan Chaggar, Kasumi Crews, Juan D Ramirez, David L H Bennett, Arnold Schwartz and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 120 citations in OpenAlex.

  1. Randomized Double-Blind Trial of Pregabalin Versus Placebo in Conjunction With Palliative Radiotherapy for Cancer-Induced Bone Pain.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2016
    Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Mirogabalin as a novel calcium channel αFrontiers in pharmacology · 2024
    Review
  13. The importance of cache domains in αChannels (Austin, Tex.) · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Voltage-gated calcium channel subunit αFrontiers in molecular neuroscience · 2023
    Article
  18. Pathophysiological Roles of Auxiliary Calcium Channel αHandbook of experimental pharmacology · 2023
    Article
  19. Article
  20. A compendium of validated pain genes.WIREs mechanisms of disease · 2022
    Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Ryan PatelDepartment of Neuroscience, Physiology and Pharmacology, University College London, London, WC1E 6BT, United Kingdom, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, OX1 2JD, United Kingdom, and University of Cincinnati, College of Medicine, Cincinnati, Ohio 45229.
Claudia S Bauer
Manuela Nieto-Rostro
Wojciech Margas
Laurent Ferron
Kanchan Chaggar
Kasumi Crews
Juan D Ramirez
David L H Bennett
Arnold Schwartz
Anthony H Dickenson
Annette C Dolphin
University College London · GBJohn Radcliffe Hospital · GBUniversity of Cincinnati Medical Center · US

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council G0700368Medical Research Council G0801756Medical Research Council G0901758Wellcome Trust 095698Wellcome Trust 095698/Z/11/ZWellcome Trust 098360Wellcome Trust 098360/Z/12/Z
6 · The paper itself

Abstract

The α2δ-1 subunit of voltage-gated calcium channels is upregulated after sensory nerve injury and is also the therapeutic target of gabapentinoid drugs. It is therefore likely to play a key role in the development of neuropathic pain. In this study, we have examined mice in which α2δ-1 gene expression is disrupted, to determine whether α2δ-1 is involved in various modalities of nociception, and for the development of behavioral hypersensitivity after partial sciatic nerve ligation (PSNL). We find that naive α2δ-1(-/-) mice show a marked behavioral deficit in mechanical and cold sensitivity, but no change in thermal nociception threshold. The lower mechanical sensitivity is mirrored by a reduced in vivo electrophysiological response of dorsal horn wide dynamic range neurons. The CaV2.2 level is reduced in brain and spinal cord synaptosomes from α2δ-1(-/-) mice, and α2δ-1(-/-) DRG neurons exhibit lower calcium channel current density. Furthermore, a significantly smaller number of DRG neurons respond to the TRPM8 agonist menthol. After PSNL, α2δ-1(-/-) mice show delayed mechanical hypersensitivity, which only develops at 11 d after surgery, whereas in wild-type littermates it is maximal at the earliest time point measured (3 d). There is no compensatory upregulation of α2δ-2 or α2δ-3 after PSNL in α2δ-1(-/-) mice, and other transcripts, including neuropeptide Y and activating transcription factor-3, are upregulated normally. Furthermore, the ability of pregabalin to alleviate mechanical hypersensitivity is lost in PSNL α2δ-1(-/-) mice. Thus, α2δ-1 is essential for rapid development of mechanical hypersensitivity in a nerve injury model of neuropathic pain.

Indexed as

AnimalsCalcium ChannelsCold TemperatureGanglia, SpinalHyperalgesiaMiceMice, KnockoutNeuralgiaPain ThresholdPeripheral Nerve InjuriesPhysical StimulationSciatic NerveSensory Receptor CellsCalcium Channels

Identifiers

PMID24133248
PMCPMC3797367
OpenAlexW1988016240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.